Skip to main content

Breast and Gynecologic Cancers

Conducts and fosters research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and related precursor conditions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Diabetes Prevention Program Outcomes Study (DPPOS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Altshuler, Rachel, Ph.D. rachel.altshuler@nih.gov 240-276-5873	5E304	Program Officer \| Breast and Gynecologic Cancer
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	Brofsky, Emma, M.S.P.H. emma.brofsky@nih.gov 240-276-7532	5E314	Program Analyst \| Breast and Gynecologic Cancer
	Dimond, Eileen, R.N., M.S. eileen.dimond@nih.gov 240-276-7086	5E332	Nurse Consultant \| Breast and Gynecologic Cancer
	Frech, Maria Silvina, Ph.D., M.S. maria.frech@nih.gov 240-276-5302	5E320	Program Officer \| Breast and Gynecologic Cancer
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Perloff, Marjorie, M.D. marjorie.perloff@nih.gov 240-276-7097	5E544	Program Officer \| Breast and Gynecologic Cancer
	Rubinstein, Wendy, M.D., Ph.D. wendy.rubinstein@nih.gov	5E436	Program Officer \| Breast and Gynecologic Cancer
	Sahasrabuddhe, Vikrant, M.B.B.S., M.P.H., Dr.P.H. vikrant.sahasrabuddhe@nih.gov 240-276-7332	5E444	Deputy Chief \| Breast and Gynecologic Cancer
	Samimi, Goli, Ph.D., M.P.H. goli.samimi@nih.gov 240-276-6582	5E336	Program Officer \| Breast and Gynecologic Cancer
	Sauter, Edward, M.D., Ph.D. edward.sauter@nih.gov 240-276-7657	5E338	Program Officer \| Breast and Gynecologic Cancer
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Wood (Gunn), Kristen, B.S.N. kristen.gunn@nih.gov	5E326	Nurse Consultant \| Breast and Gynecologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Shirwan, Haval	University Of Missouri-Columbia United States	Developing a novel agonist of CD137 for cancer immunoprevention	5UG3CA290305-02	Altaf Mohammed, Ph.D.
Shu, Xiao-Ou	Vanderbilt University Medical Center United States	Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer	5R01CA227133-05	Matthew Young, Ph.D.
Shureiqi, Imad	University Of Michigan At Ann Arbor United States	ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism	5R01CA266223-04	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Siddique, Shahzad	Commonspirit Health Research Institute United States	CIRI Oncology Research Alliance	3UG1CA189809-11S1	Vanessa A. White, M.P.H.
Sidransky, David	Johns Hopkins University United States	Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma	5R01CA265975-04	Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C	University Of Iowa United States	Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers	5R01CA267820-03	Nicholas Hodges, Ph.D.
Sigel, Keith Magnus	Icahn School Of Medicine At Mount Sinai United States	The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors	4R01CA256660-05	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Simeone, Diane M	University Of California, San Diego United States	Biomarker Validation in Pancreatic Cystic Neoplasms	5U01CA282272-03	Matthew Young, Ph.D.
Siminski, Suzanne M.	Frontier Sci & Technology Rsch Fdn, Inc United States	CASCADE Coordinating Center	5U24CA275417-04	Maria Silvina Frech, Ph.D., M.S.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States	5U01CA230694-05
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules	4U01CA283935-03	Sidney Fu, M.D.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis	5R01CA222900-06
Singal, Amit	Ut Southwestern Medical Center United States	Clinical Validation Center for Hepatocellular Carcinoma	5U01CA271887-04	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Siskind, Leah J	University Of Louisville United States	Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease	1R01CA305985-01	Marjorie Perloff, M.D.
Skates, Steven J	Massachusetts General Hospital United States	Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls	5U01CA260758-05	Claire Zhu, Ph.D.